Assembly Biosciences, Inc. (ASMB)

NASDAQ: ASMB · Real-Time Price · USD

21.12

+0.94 (4.66%)

At close: Nov 13, 2026, 4:00 PM EST

21.28

+0.16 (0.76%)

After-hours: Nov 13, 2026, 7:30 PM EST

Assembly Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	29.07	58.45	38.34	19.84	52.42	45.63
Short-Term Investments	285.19	189.66	73.74	110.41	39.19	101
Cash & Short-Term Investments	314.26	248.11	112.08	130.25	91.61	146.63
Cash Growth	35.13%	121.37%	-13.95%	42.18%	-37.52%	-32.25%
Accounts Receivable	0.58	0.97	-	0.04	0.94	0.34
Other Receivables	1.5	1.5	0.4	0.3	0.3	-
Receivables	2.08	2.47	0.4	0.34	1.24	0.34
Prepaid Expenses	4.82	3.97	3.02	3.2	4.11	7.24
Total Current Assets	321.16	254.55	115.5	133.79	96.97	154.2
Property, Plant & Equipment	2.37	2.73	3.35	2.72	3.94	7.18
Long-Term Investments	-	-	-	-	-	27.97
Long-Term Deferred Charges	-	-	-	-	0.2	0.2
Other Long-Term Assets	1.75	0.31	0.31	0.31	0.69	1.5
Total Assets	325.29	257.59	119.17	136.82	101.79	191.06

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.18	1.17	0.59	0.46	2.49	2.66
Accrued Expenses	7.36	10.14	9.14	6.63	9.84	10.26
Current Portion of Leases	0.64	0.57	0.46	1.22	3.36	3.15
Current Unearned Revenue	13.74	36.9	37.62	30.92	-	-
Other Current Liabilities	-	-	-	-	0.6	-
Total Current Liabilities	24.92	48.78	47.8	39.23	16.3	16.07
Long-Term Leases	1.57	2.06	2.63	1.12	0.1	3.33
Long-Term Unearned Revenue	-	-	35.38	55.38	2.73	2.73
Total Liabilities	26.49	50.84	85.81	95.73	19.13	22.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.01	0.01	0	0.05
Additional Paid-In Capital	1,165	1,039	859.49	826.92	807.98	800.73
Retained Earnings	-865.24	-832.05	-825.93	-785.75	-724.52	-631.43
Comprehensive Income & Other	-0.99	-0.04	-0.21	-0.08	-0.8	-0.42
Shareholders' Equity	298.79	206.75	33.36	41.1	82.66	168.93
Total Liabilities & Equity	325.29	257.59	119.17	136.82	101.79	191.06

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.21	2.63	3.09	2.34	3.47	6.48
Net Cash (Debt)	312.06	245.48	108.99	127.91	88.15	168.12
Net Cash Growth	35.79%	125.23%	-14.79%	45.11%	-47.57%	-18.50%
Net Cash Per Share	16.75	21.90	18.15	27.94	21.85	46.61
Filing Date Shares Outstanding	20.48	15.86	7.5	5.48	4.33	4.01
Total Common Shares Outstanding	20.37	15.86	7.46	5.48	4.07	4.01
Working Capital	296.24	205.77	67.7	94.56	80.67	138.13
Book Value Per Share	14.67	13.04	4.47	7.50	20.29	42.13
Tangible Book Value	298.79	206.75	33.36	41.1	82.66	168.93
Tangible Book Value Per Share	14.67	13.04	4.47	7.50	20.29	42.13
Machinery	-	-	-	-	0.8	0.72
Leasehold Improvements	-	-	-	-	1.63	1.63

SEC Filings: 10-K · 10-Q